Latest Cost Reduction News

Inghams Group reported a stable FY25 underlying EBITDA pre AASB 16 at $236.4 million, with strong New Zealand growth offsetting challenges in Australia. The company outlines a cautious but optimistic FY26 outlook, focusing on cost reductions and operational efficiencies.

Inghams Group reported a stable underlying EBITDA of $236.4 million for FY25 despite softer market conditions and customer changes, while guiding for a modest earnings dip in FY26 as cost reduction programs take effect.

Australian Vintage Limited reported a strong FY25 with significant profit growth despite flat revenue, underpinned by innovation and cost-cutting initiatives. The company aims for positive free cash flow in FY26, propelled by global brand expansion and operational efficiencies.

Australian Vintage reported a slight sales dip in FY25 but improved earnings and cash flow, setting the stage for a transformational FY26 driven by innovative brands and strategic expansion.

Aerometrex has confirmed Robert Veitch as its new CEO and Managing Director, following a strategic overhaul that delivered $2 million in annual cost savings and boosted its MetroMap revenue stream.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Tinybeans Group Ltd reported a significant reduction in losses and a 12% rise in subscription revenue for FY25, driven by a strategic pivot away from advertising. The company’s restructuring efforts have improved cash flow and positioned it for sustainable growth.

Downer EDI Limited reported a robust FY25 with a 33% rise in underlying NPATA and announced a $230 million share buy-back, underscoring confidence in its transformation and growth outlook. The company’s disciplined portfolio simplification and operational improvements set the stage for steady FY26 performance despite short-term market softness.

Sonic Healthcare reported solid FY2025 results with revenue up 7.6% and a steady profit increase, while declaring a 63-cent final dividend. The company’s recent German acquisition and ongoing synergy efforts set the stage for robust earnings growth in FY2026.

Downer EDI reports a robust FY25 with statutory profit soaring 82% and announces a $230 million share buy-back, signaling confidence in its ongoing transformation.

Whitehaven Coal reported a robust FY25 with $1.4 billion underlying EBITDA and strong production growth from Queensland acquisitions, maintaining a solid balance sheet and setting ambitious cost-saving targets for FY26.